Educational Video Versus In-person Genetic Counseling for Hereditary Cancer

Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (Other)
Overall Status
Completed
CT.gov ID
NCT05805982
Collaborator
(none)
251
1
2
28.8
8.7

Study Details

Study Description

Brief Summary

The identification of mutations in cancer susceptibility genes is important as it makes it possible to recommend specific cancer treatments, implement risk reduction strategies or early detection of cancer, and identify family members at risk. The guidelines for evaluating patients who are candidates for genetic testing recommend pre-test genetic counseling. However, the limited number of specialists trained to provide genetic counseling worldwide, and particularly in developing countries such as Mexico, makes it difficult to implement such recommendations. The present proposal aims to compare, through a randomized non-inferiority study, a pre-test education strategy using a pre-recorded video against in-person counseling. This strategy could potentially increase access in places with limited resources.

The general hypothesis of the research is that patients who are candidates for cancer genetic susceptibility testing who receive pre-test education via video will consent to genetic testing in the same proportion as those who receive it during an in-person visit.

The specific objectives of the study include: 1) to compare the proportion of patients who are tested in both groups; 2) to assess knowledge about hereditary cancer in both groups after the intervention; 3) assess anxiety symptoms in both groups after the intervention; and 4) assess satisfaction with the information received during the intervention.Patients >18 years of age who meet the criteria for genetic testing to evaluate genetic cancer susceptibility genes and who have not previously undergone genetic testing or genetic counseling will be invited. The intervention group will receive education via pre-recorded video and the control group will receive genetic counseling during an in-person consultation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Educational Video
  • Behavioral: In person genetic cancer counseling
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
251 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Randomized Non Inferiority Trial of Educational Video Versus In-person Genetic Counseling for Hereditary Cancer
Actual Study Start Date :
Aug 10, 2020
Actual Primary Completion Date :
Nov 30, 2022
Actual Study Completion Date :
Jan 3, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Educational Video

The patient will watch a 15-minute video on an electronic tablet that includes the following items: What is hereditary cancer? Inheritance risk Who are candidates for a genetic test? What is a genetic testing and how can it help? What types of results can be expected from genetic testing? Reactions to the result of the genetic test Clinical care according to the results Any common questions? When the patient finish watching the video, he/she would have the opportunity to resolve any doubts.

Behavioral: Educational Video
Pre-recorded educational video including hereditary cancer information, genetic cancer testing candidates, types of testing, type of results, benefits and risks, recommendations according to results, inheritance and common questions.

Active Comparator: In-Person genetic counseling

Patients will receive pre-test genetic counseling in person with a specialist using the usual protocols existing at the Institute and systematically includes the following: Family history of cancer Personal cancer risk assessment Education on inheritance and disease expression Types of tests and results (positive, negative and variants of uncertain significance). Limitations of the genetic study Preparation of possible outcomes according to results Risks Additional information: confidentiality of the results, costs and test options. Opportunity will be given to resolve doubts

Behavioral: In person genetic cancer counseling
Includes: Family history of cancer (3-generation family tree) Personal Cancer Risk Assessment Education on inheritance and expression of disease Types of tests Preparation on possible outcomes according to results Obtaining consent for test Opportunity to solve doubts

Outcome Measures

Primary Outcome Measures

  1. Genetic testing acceptance [up to 12 weeks]

    Proportion of patients that accept to undergo a genetic testing

Secondary Outcome Measures

  1. Genetic cancer knowledge change (pre and post intervention) [up to 24 hours after intervention]

    Knowgene questionnaire

  2. Anxiety level (pre and post intervention) [up to 24 hours after intervention]

    GAD-7 questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Meet cancer genetic testing criteria
Exclusion Criteria:
  • Had a genetic testing before

  • Had genetic counseling before

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico

Sponsors and Collaborators

  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yanin Chavarri Guerra, Principal Investigator, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
ClinicalTrials.gov Identifier:
NCT05805982
Other Study ID Numbers:
  • HEM-3442
First Posted:
Apr 10, 2023
Last Update Posted:
Apr 10, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Apr 10, 2023